Literature DB >> 12447671

Expression profiles of p53, p63, and p73 in benign salivary gland tumors.

Anette Weber1, Larissa Langhanki, Alexander Schütz, Andreas Gerstner, Friedrich Bootz, Christian Wittekind, Andrea Tannapfel.   

Abstract

The tumor-suppressor protein p53 has recently been shown to belong to a family that includes two structurally related proteins, p63 and p73. In contrast to p53, p63 and p73 play an essential role in epithelial development, stem cell identity and cellular differentiation. Salivary gland tumors carry a wide spectrum of histopathological forms, which may share a common single-cell origin from the epithelial progenitor basal duct cells and have a different tendency of malignant progression. This study was performed to examine the expression of p53, p63, and p73 in benign salivary gland tumors. Expression and mutation of p53, p73, and p63 were examined by direct DNA sequencing, reverse transcription PCR using isoform-specific primers, and by immunohistochemistry in normal parotid tissue ( n=10), and various tumors of the salivary gland (42 pleomorphic adenomas, 12 myoepitheliomas, 8 basal cell adenomas, 5 oncocytomas, 5 canalicular adenomas, and 20 adenolymphomas). In normal parotid tissue the expression of p63 and p73 was restricted to few basal and myoepithelial cells. Ductal luminal and acinus cells were completely negative for the expression of all three family members. In contrast, in salivary gland tumors, strong nuclear staining for p63 and p73 was observed. Myoepithelial and basaloid cells and the basal epithelial layer of adenolyphomas and oncocytomas were positive for p63 and also, to a lesser extent, to p73. Mutations of p53 were detected in 4 of 42 (10%) pleomorphic adenomas, in 3 of 12 (25%) myoepitheliomas, and in 1 of 8 (13%) basal cell adenomas but not in other tumors. We failed to detect specific mutations of p63 and p73. Using isoform-specific PCR, we found that all isoforms of p63 were expressed in normal parotid tissue whereas the pleomorphic adenomas, myoepitehliomas, and basal cell adenomas dominantly expressed the transactivation-incompetent truncated isoforms. Our data indicate that p63 and p73 are upregulated in salivary gland tumors and may serve as a marker of epithelial and myoepithelial progenitor cells in salivary glands. The prevalence of p53 mutations and the observation of the expression of DeltaNp63 isoforms only in pleomorphic adenomas, myoepitheliomas, and also basal cell adenomas may reflect their possible malignant potential.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447671     DOI: 10.1007/s00428-002-0705-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  Mammary epithelial cell polarity is regulated differentially by p73 isoforms via epithelial-to-mesenchymal transition.

Authors:  Yanhong Zhang; Wensheng Yan; Yong Sam Jung; Xinbin Chen
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

Review 2.  Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature.

Authors:  Lester D R Thompson; Justin L Bauer; Simion Chiosea; Jonathan B McHugh; Raja R Seethala; Markku Miettinen; Susan Müller
Journal:  Head Neck Pathol       Date:  2014-08-21

3.  p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma.

Authors:  Jonathan B McHugh; Aaron P Hoschar; Mari Dvorakova; Anil V Parwani; E Leon Barnes; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2007-10-26

4.  Loss of heterozygosity occurs predominantly, but not exclusively, in the epithelial compartment of pleomorphic adenoma.

Authors:  Micaela Poetsch; Anett Zimmermann; Eduard Wolf; Britta Kleist
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

5.  Cytogenetic analysis of myoepithelial cell carcinoma of salivary gland.

Authors:  Elisabetta Magrini; Antonella Pragliola; Anna Farnedi; Christine M Betts; Roberto Cocchi; Maria P Foschini
Journal:  Virchows Arch       Date:  2004-01       Impact factor: 4.064

6.  Basal Cell Adenoma of Submandibular Salivary Gland: A Case Report and Literature Review.

Authors:  Pravin N Lambade; Dilpreet Rajkhokar; Dipti Lambade
Journal:  J Maxillofac Oral Surg       Date:  2014-10-08

7.  Plasmacytoid cells in salivary-gland pleomorphic adenomas: evidence of luminal cell differentiation.

Authors:  Yuzo Ogawa; Mitsunobu Kishino; Yukako Atsumi; Masaya Kimoto; Yasuo Fukuda; Takeshi Ishida; Naokuni Ijuhin
Journal:  Virchows Arch       Date:  2003-08-28       Impact factor: 4.064

8.  Assessment of TP53 mutations in benign and malignant salivary gland neoplasms.

Authors:  Carolina Cavaliéri Gomes; Marina Gonçalves Diniz; Lissur Azevedo Orsine; Alessandra Pires Duarte; Thiago Fonseca-Silva; Brendan I Conn; Luiz De Marco; Cláudia Maria Pereira; Ricardo Santiago Gomez
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

Review 9.  Synchronous bilateral epithelial-myoepithelial carcinoma of the parotid gland: case report and review of the literature.

Authors:  J van Tongeren; D H K V Creytens; E V Meulemans; R B J de Bondt; J de Jong; J J Manni
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-08       Impact factor: 2.503

10.  Establishment and characterization of pleomorphic adenoma cell systems: an in-vitro demonstration of carcinomas arising secondarily from adenomas in the salivary gland.

Authors:  Satoshi Maruyama; Jun Cheng; Susumu Shingaki; Takashi Tamura; Shuichi Asakawa; Shinsei Minoshima; Yoshiko Shimizu; Nobuyoshi Shimizu; Takashi Saku
Journal:  BMC Cancer       Date:  2009-07-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.